S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'

Oragenics Stock Price, News & Analysis (NYSEAMERICAN:OGEN)

$3.58
-0.12 (-3.24%)
(As of 11/30/2023 ET)
Compare
Today's Range
$3.44
$3.80
50-Day Range
$2.94
$4.18
52-Week Range
$2.60
$12.54
Volume
8,447 shs
Average Volume
3,904 shs
Market Capitalization
$9.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

OGEN stock logo

About Oragenics Stock (NYSEAMERICAN:OGEN)

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Stock Price History

OGEN Stock News Headlines

StockNews.com Begins Coverage on Oragenics (NYSEAMERICAN:OGEN)
Oragenics, Inc. (UAV.F)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Oragenics Issues Update to Shareholders
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Oragenics, Inc. Announces Private Placement
Oragenics, Inc. Regains Compliance with NYSE American
Oragenics, Inc. Receives NYSE American Notice
Oragenics, Inc. Announces New Chair
Oragenics Inc OGEN Stock Quote
See More Headlines
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
11/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:OGEN
Employees
6
Year Founded
N/A

Profitability

Net Income
$-14,290,000.00
Pretax Margin
-26,700.00%

Debt

Sales & Book Value

Annual Sales
$130,000.00
Book Value
$1.91 per share

Miscellaneous

Free Float
1,937,000
Market Cap
$9.20 million
Optionable
Not Optionable
Beta
0.53
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Kimberly M. Murphy (Age 60)
    President, CEO & Director
    Comp: $497.03k
  • Ms. Janet Huffman (Age 51)
    CFO, Secretary & Treasurer














OGEN Stock Analysis - Frequently Asked Questions

How have OGEN shares performed in 2023?

Oragenics' stock was trading at $0.1051 at the start of the year. Since then, OGEN stock has increased by 3,306.3% and is now trading at $3.58.
View the best growth stocks for 2023 here
.

Are investors shorting Oragenics?

Oragenics saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 52,400 shares, a drop of 25.9% from the October 15th total of 70,700 shares. Based on an average daily trading volume, of 17,400 shares, the days-to-cover ratio is presently 3.0 days. Currently, 2.5% of the shares of the stock are sold short.
View Oragenics' Short Interest
.

How were Oragenics' earnings last quarter?

Oragenics, Inc. (NYSEAMERICAN:OGEN) released its earnings results on Thursday, November, 9th. The biotechnology company reported ($0.85) EPS for the quarter. The biotechnology company had revenue of $0.01 million for the quarter.

When did Oragenics' stock split?

Shares of Oragenics reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Oragenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Imunon (CLSN), Jaguar Health (JAGX), Biocept (BIOC), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Amarin (AMRN), Heat Biologics (HTBX), Idera Pharmaceuticals (IDRA) and Achieve Life Sciences (ACHV).

How do I buy shares of Oragenics?

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:OGEN) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -